Seven oral traditional Chinese medicine combined with chemotherapy for the treatment of non-small cell lung cancer: a network meta-analysis-Reference-Cited by-同舟云学术

Seven oral traditional Chinese medicine combined with chemotherapy for the treatment of non-small cell lung cancer: a network meta-analysis

Published:2024-05-13 Issue:1 Volume:62 Page:404-422
ISSN:1388-0209
Container-title:Pharmaceutical Biology
language:en
Short-container-title:Pharmaceutical Biology

Author:

Liu Kefeng¹²,Li Qiong³,Lu Xiaojing¹²,Fan Xintong¹,Yang Yongjie¹²,Xie Wei⁴,Kang Jian¹²,Sun Shusen⁵,Zhao Jie¹⁶

Affiliation:

1. Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

2. Henan Drug Clinical Comprehensive Evaluation Center, Zhengzhou, China

3. Department of Pharmacy, Zhengzhou Second People’s Hospital, Zhengzhou, China

4. Department of Pharmacy, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou, China

5. College of Pharmacy and Health Sciences, Western New England University, Springfield, Massachusetts, USA

6. National Engineering Laboratory of Internet Medical System and Application, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

Funder

Henan Key Research and Development and Promotion Project

Clinical Pharmacy Research Fund of the Chinese Society of Clinical Pharmacy in 2022

Henan Medical Science and Technology Joint Construction Project

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/13880209.2024.2351940

Reference84 articles.

1. Tropomyosin receptor kinase (TRK) biology and the role of NTRK gene fusions in cancer

2. Clinical study of compound cantharides capsule combined with chemotherapy in the treatment of advanced non-small cell lung cancer;Cai Y.;World Latest Med Info,2019

3. Compound taxane combined with chemotherapy and chemotherapy alone A controlled study of advanced non-small cell lung cancer;Cao J;The Worl Clin Med,2016

4. Graphical Tools for Network Meta-Analysis in STATA

5. Clinical efficacy of Zilongjin tablets in combined with docetaxel plus cisplatin in the treatment of intermediate to advanced non-small cell lung cancer;Chen CR;China Prac Med,2011